4D Molecular Therapeutics (FDMT)
(Real Time Quote from BATS)
$24.16 USD
-0.74 (-2.97%)
Updated May 29, 2024 10:44 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.72 |
EPS Last Quarter | -0.66 |
Last EPS Surprise | 9.59% |
ABR | 1.10 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.00 |
Next Year | -3.09 |
EPS (TTM) | -2.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.43M | 1.52M | 5.65M | 11.76M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 3.30M | 3.30M | 13.00M | 16.90M |
Low Estimate | 0.50M | 0.50M | 1.90M | 2.09M |
Year ago Sales | 0.24M | 20.20M | 20.72M | 5.65M |
Year over Year Growth Est. | 497.08% | -92.50% | -72.73% | 108.19% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.72 | -0.74 | -3.00 | -3.09 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | -0.71 | -0.74 | -2.89 | -3.33 |
High Estimate | -0.67 | -0.70 | -2.63 | -0.95 |
Low Estimate | -0.77 | -0.77 | -3.29 | -4.55 |
Year ago EPS | -0.77 | -0.24 | -2.58 | -3.00 |
Year over Year Growth Est. | 6.49% | -208.33% | -16.28% | -2.92% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.72 | -0.74 | -3.00 | -3.09 |
7 Days Ago | -0.72 | -0.74 | -3.00 | -3.09 |
30 Days Ago | -0.76 | -0.78 | -3.12 | -3.15 |
60 Days Ago | -0.74 | -0.75 | -3.07 | -3.76 |
90 Days Ago | -0.68 | -0.68 | -3.10 | -3.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.72 | -0.74 | -2.98 | -3.09 |
Zacks Consensus Estimate | -0.72 | -0.74 | -3.00 | -3.09 |
Earnings ESP | 0.00% | 0.00% | 0.83% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.66 | -0.77 | -0.24 | -0.77 | NA |
Estimate | -0.73 | -0.68 | -0.67 | -0.77 | NA |
Difference | 0.07 | -0.09 | 0.43 | 0.00 | 0.10 |
Surprise | 9.59% | -13.24% | 64.18% | 0.00% | 15.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more